Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Gene Therapy

Peptide nucleic acids progress for gene editing and antisense drugs

These lab-made molecules can bind to genes more strongly than DNA and RNA do, making them promising drug candidates and genetic tools

by Rachel Brazil, special to C&EN
March 28, 2023 | A version of this story appeared in Volume 101, Issue 11

Article:

This article has been sent to the following recipient: